An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors
Abdelbaki, Mohamed S., DeWire Schottmiller, Mariko Dawn, Cripe, Timothy P., Curry, Richard C., Cruze, Charles A., Her, Leah, Demko, Suzanne, Casey, Denise, Setty, Bhuvana
Published in Heliyon (01.12.2022)
Published in Heliyon (01.12.2022)
Get full text
Journal Article